Onderneming Hemispherx BioPharma, Inc Nyse
Aandelen
US42366C1036
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Ampligen and Other Drugs
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +43,26% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +43,26% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Equels
CEO | Chief Executive Officer | 71 | 17-11-08 |
Robert Dickey
DFI | Director of Finance/CFO | 68 | 04-04-22 |
Chief Tech/Sci/R&D Officer | - | 01-06-22 | |
Peter Rodino
COO | Chief Operating Officer | 72 | 23-07-13 |
David R. Strayer
CTO | Chief Tech/Sci/R&D Officer | 78 | 01-01-86 |
Jenene Thomas
IRC | Investor Relations Contact | 52 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nancy K. Bryan
BRD | Director/Board Member | 66 | 28-03-23 |
William Mitchell
CHM | Chairman | 89 | 01-07-98 |
Thomas Equels
CEO | Chief Executive Officer | 71 | 17-11-08 |
Peter Rodino
COO | Chief Operating Officer | 72 | 23-07-13 |
Director/Board Member | 70 | 01-08-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 50 888 333 | 46 402 300 ( 91,18 %) | 0 | 91,18 % |
Aandeel B | 0 | 689 | 0 | 0 |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,96% | 105 mld. | |
-1,43% | 104 mld. | |
+4,40% | 22,94 mld. | |
-12,15% | 22,34 mld. | |
-4,36% | 19,25 mld. | |
-39,98% | 17,08 mld. | |
-10,04% | 16,96 mld. | |
+6,79% | 14,16 mld. | |
+38,61% | 12,63 mld. |